• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CluePoints hires Borders and Estrella

CluePoints hires Borders and Estrella

December 12, 2017
CenterWatch Staff

CluePoints, a provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has announced two new strategic appointments to strengthen its business development team. Nick Borders and Rob Estrella join the CluePoints U.S. team to support its impressive global business growth, allowing the company to increase its expanding client base across North America.

Nick Borders joins CluePoints having previously served as Associate Director of Business Development for Biomedical Systems where he demonstrated key skills in managing both new and existing accounts, exceeding sales targets and creating strategic project plans. With over nine years of experience as the Director of Business Development for TransPerfect, Rob Estrella has an extensive proven sales track record managing a Life Science & Technology enterprise sales team resulting in 500+ new client relationships. Both will play key roles in capturing commercial opportunities across the U.S.

Following the opening of the new Wayne office in May and the continued year on year growth with global partnerships across Europe, North America and Asia-Pacific, CluePoints is leading the industry in the provision of its first-of-a-kind Risk-Based Monitoring and Data Quality Oversight solutions to top ten Biopharmaceutical companies as well as the small and mid-size sponsor and CRO sector. The fact that CluePoints is entirely independent and is solely focused on this disruptive technology for Central Statistical Monitoring means that the solution can provide the ultimate objective assessment of clinical trial and operational data, upholding the obligations of ICH E6 R2 and supporting FDA’s own approach to statistical interrogation of marketing submission data.

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing